Who are the key players in the pulmonary arterial hypertension market?

Some key players operating in the pulmonary arterial hypertension market include United Therapeutics Corporation; Bayer; Gilead Sciences, Inc.; Johnson & Johnson; Viatris Inc.; GlaxoSmithKline; Sandoz Inc. (Novartis); Lupin Pharmaceuticals, Inc.; Sun Pharmaceutical Industries, Inc.; and Teva Pharmaceuticals Inc.

What are the factors driving the pulmonary arterial hypertension market?

Growing initiatives by key market players, high prevalence of PAH, adoption rate, availability of reimbursement, and entry of generics are some of the key drivers of this market.

How big is the pulmonary arterial hypertension market?

The pulmonary arterial hypertension market size was exhibited at USD 8.15 billion in 2024 and is projected to hit around USD 13.92 billion by 2034, growing at a CAGR of 5.5% during the forecast period 2024 to 2034.

Which segment accounted for the largest pulmonary arterial hypertension market share?

North America held over 40% share of the pulmonary arterial hypertension market in 2024. The large share of the North American region is due to the developed healthcare infrastructure in the U.S. and Canada that facilitates access to advanced therapeutics. Also, increased awareness, a high diagnosis rate, and supportive government initiatives support the market growth in this region.

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2034

Report Details

Report Code:6905
Category:Healthcare
No. of Pages:150+
Format:PDF/PPT/Excel
Published:April 2025
Historical Year:2021-2023
Base Year:2024
Estimated Year:2025-2034

Get a Sample

Proceed To Buy

Global Deep Dive Analysis

USD 4500

Single Region (NA,EU,APAC,LA,MEA)

USD 3900

Databook

USD 1900

Competitive Intelligence

USD 1200

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others

Ask To Expert